Recro Pharma CEO Gerri Henwood's 2018 pay rises 16% to $2.4M

Recro Pharma reports 2018 executive compensation

By ExecPay News

Published: March 20, 2019

Recro Pharma reported fiscal year 2018 executive compensation information on March 20, 2019.
In 2018, three executives at Recro Pharma received on average a compensation package of $1.5M, a 4% increase compared to previous year.
Average pay of disclosed executives at Recro Pharma
Gerri Henwood, Chief Executive Officer, received $2.4M in total, which increased by 16% compared to 2017. 42% of Henwood's compensation, or $1M, was in stock awards. Henwood also received $184K in non-equity incentive plan, $600K in option awards, $599K in salary, as well as $37K in other compensation.
Michael Celano, Chief Operating Officer, received a compensation package of $1.2M, which increased by 21% compared to previous year. 35% of the compensation package, or $415K, was in salary.
Ryan Lake, Chief Financial Officer, earned $784K in 2018.

Related executives

Gerri Henwood

Recro Pharma

Chief Executive Officer

Michael Celano

Recro Pharma

Chief Operating Officer

Ryan Lake

Recro Pharma

Chief Financial Officer

You may also like

Source: SEC filing on March 20, 2019.